Fed. Circ. Bats Down Helsinn Bid To Stay On-Sale Bar Ruling
The Federal Circuit on Monday rejected Helsinn Healthcare's request to stay its ruling invalidating four patents related to an anti-nausea drug while the company seeks to put its case before the...To view the full article, register now.
Already a subscriber? Click here to view full article